Celgene announced on Tuesday that it will acquire Receptos for $232 per share in cash for a total of about $7.2 billion net cash acquired.
Celgene announced on Tuesday that it will acquire Receptos for $232 per share in cash for a total of about $7.2 billion net cash acquired.